HYPERTENSION, BLOOD VISCOSITY, AND CARDIOVASCULAR MORBIDITY IN RENAL FAILURE: IMPLICATIONS OF ERYTHROPOIETIN THERAPY

The Lancet

Volumn 331, Issue 8577, 1988, Pages 97-100

  Raine, A E G ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

BLOOD VISCOSITY; CHRONIC KIDNEY FAILURE; HUMAN; HYPERTENSION; SHORT SURVEY; SIDE EFFECT;

BLOOD VISCOSITY; CARDIOVASCULAR DISEASES; ERYTHROPOIETIN; HEMATOCRIT; HUMAN; HYPERTENSION; KIDNEY FAILURE, CHRONIC; RECOMBINANT PROTEINS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0023837876     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(88)90293-0     Document Type: Article

References (45)

1. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis
2. Correction of the anaemia of end-stage renal disease with recombinant human erythropoietin Results of a combined phase I and II clinical trial
3. Potential side-effects of erythropoietin
4. Cardiovascular complications after renal transplantation
5. Importance of hypertension as a major risk factor in cardiovascular disease
6. Survival with dialysis and transplantation in patients with end stage renal disease
7. Serum cholesterol lipoproteins and risk of coronary heart diseases
8. Morbidity and mortality in diabetics in the Framingham population
9. Update on the role of cigarette smoking in coronary artery disease
10. Accelerated atherosclerosis in prolonged maintenance hemodialysis
11. Ischaemic heart disease in patients with uraemia undergoing maintenance dialysis
12. Combined report on regular dialysis and transplantation in Europe. IX, 1978
13. The role of hypertension in hemodialysis-associated atherosclerosis
14. Maintenance haemodialysis
15. Natural history of hypertension in renal parenchymal disease
16. Hypertension in end stage renal disease
17. Hemodynamics of hypertension in chronic end-stage renal disease
18. Effects of chronic uraemia, haemodialysis and renal transplantation on plasma lipids and lipoproteins m man
19. Increased lipoprotein remnant formation in chronic renal failure
20. Polycythaemia vera: Clinical studies on a series of 127 patients managed without radiation therapy
21. Complications and causes of death in polycythaemia vera
22. Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia
23. Morbidity and mortality in pseudopolycythaemia
24. Haemoglobin and the risk of cerebral infarction. The Framingham Study
25. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia—13-year study
26. Hematocrit and the risk of coronary heart disease The Honolulu heart program
27. Mortality, haemoglobin levels and haematocrit in women
28. The hemodynamics of hypertension
29. Blood rheology
30. Hematocrit, plasma protein, plasma volume, and viscosity m early hypertensive disease
31. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects
32. Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension
33. Haemoglobin level and renal function in patients with and without hypertension
34. Hemodynamics of uremic anemia
35. Cardiac work demands and left ventricular function in end-stage renal disease
36. Sequential hemodynamic changes in end-stage renal disease and the anephric state during volume expansion
37. Hemodynamic effects of chronic alteration in hematocrit in spontaneously hypertensive rats
38. Cardiovascular structural adaptation: its role in the initiation and maintenance of primary hypertension
39. Recombinant human erythropoietin therapy in haemodialysis patients-dose determinationn and clinical experience
40. Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis
41. Clinical significance of blood viscosity
42. Placebo-controlled, double-blind study of haemodilution in peripheral arterial disease
43. Effect of haematocrit on cerebral blood flow m man
44. Acute myocardial infarction in renal transplant recipients incidence and prognosis